Fang Y I, Suzuki T, Momose K
Department of Pharmacology, School of Pharmaceutical Sciences, Showa University, Tokyo, Japan.
Biochem Mol Biol Int. 1996 Mar;38(3):501-7.
An endogenous inhibitory factor (EIF alpha) to the binding of a muscarinic antagonist, [3H]N-methyl scopolamine ([3H]NMS), has been partially (12-fold) purified from the soluble fraction of the ileal longitudinal muscle of guinea-pigs using a heat-treatment, isoelectric fractionation, and DEAE-column chromatography. The EIF alpha inhibited the [3H]NMS binding to the longitudinal muscle membrane with an IC50 of 53.6 micrograms/ml. This was about 230-fold potent than the non-specific inhibition of [3H]NMS binding by bovine serum albumin (BSA). Zn2+ (0.1 mM) almost completely blocked the inhibitory activity of EIF alpha, whereas such the effect of Zn2+ was not observed in the inhibition by BSA. These results suggest that EIF alpha inhibits the [3H]NMS binding to the muscarinic acetylcholine receptor in a different manner from non-specific interaction with the receptor.
已使用热处理、等电分级分离和DEAE柱色谱法从豚鼠回肠纵肌的可溶性部分中部分纯化(12倍)出一种对毒蕈碱拮抗剂[3H]N-甲基东莨菪碱([3H]NMS)结合的内源性抑制因子(EIFα)。EIFα抑制[3H]NMS与纵肌膜的结合,IC50为53.6微克/毫升。这比牛血清白蛋白(BSA)对[3H]NMS结合的非特异性抑制作用强约230倍。Zn2+(0.1 mM)几乎完全阻断了EIFα的抑制活性,而在BSA的抑制作用中未观察到Zn2+的这种作用。这些结果表明,EIFα以与受体非特异性相互作用不同的方式抑制[3H]NMS与毒蕈碱型乙酰胆碱受体的结合。